Cargando…

Head and Neck Cancer

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Lazim, Norhafiza Mat
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Singapore : Bentham Science Publishers, 2021.
Colección:Frontiers in Inflammation Ser.
Temas:
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Cover
  • Title
  • Copyright
  • End User License Agreement
  • Contents
  • Foreword
  • Preface
  • List of Contributors
  • Introduction to Inflammation Ecosystem in Head and Neck Cancer
  • Norhafiza Mat Lazim*
  • INTRODUCTION
  • INFLAMMATION AND CANCER
  • INFLAMMATION ECOSYSTEM AND CARCINOGENESIS
  • INFLAMMATION AND ASSOCIATION WITH GENETIC CHANGES
  • INTRATUMOURAL HETEROGENEITY
  • MACROPHAGES AND ITS ROLES IN INFLAMMATION ECOSYSTEM
  • RISK FACTORS OF HEAD AND NECK MALIGNANCY AND ROLE OF INFLAMMATION
  • Growth Factors and Inflammation Ecosystem
  • Interaction between Mediators in the Tumor Microenvironments
  • ROLE OF INFLAMMATORY MARKERS AND THEIR CRITICAL ACTION
  • Therapeutics
  • Prevention of Head and Neck Malignancy with Anti-Inflammation Agents
  • Prognostications of Head and Neck Malignancy
  • The Negative Impact of Inflammation for Future Research Consideration
  • FUTURE PROSPECT IN THE HEAD AND NECK MALIGNANCY MANAGEMENT
  • CONCLUSION
  • CONSENT FOR PUBLICATION
  • CONFLICT OF INTEREST
  • ACKNOWLEDGEMENTS
  • REFERENCES
  • Types of Head and Neck Malignancy
  • Gabriela Ramírez-Arroyo1,*, Juan Carlos Hernaiz-Leonardo1, Michelle Marvin-Huergo1 and Mario Sergio Dávalos-Fuentes1
  • INTRODUCTION
  • EPIDEMIOLOGY OF HEAD andamp
  • NECK CANCER
  • TYPES OF HEAD AND NECK CANCER
  • Laryngeal and Hypopharyngeal Cancer
  • Laryngeal Cancer
  • Hypopharyngeal Cancer
  • Oral Cavity and Oropharyngeal Cancer
  • Oral Cavity Cancer
  • Oropharyngeal Cancer
  • Salivary Gland Malignancy
  • Nasal and Paranasal Sinus Cancer
  • Nasopharyngeal Cancer
  • Thyroid Malignancy
  • Metastatic Carcinoma of Unknown Primary (MCUP)
  • Lymphoma
  • Miscellaneous: Esophageal, Cutaneous, Temporal Bone Cancer
  • Carcinoma of the Cervical Esophagus
  • Skin Cancer
  • Temporal Bone Carcinoma
  • MOLECULAR AND GENOMIC LANDSCAPE OF HEAD AND NECK MALIGNANCY
  • Laryngeal Cancer.
  • Oropharyngeal Cancer
  • Thyroid Cancer
  • Lymphoma
  • CONCLUSION
  • CONSENT FOR PUBLICATION
  • CONFLICT OF INTEREST
  • ACKNOWLEDGEMENTS
  • REFERENCES
  • Histological Classification of Head and Neck Tumors
  • Sharifah Emilia Tuan Sharif1 and Anani Aila Mat Zin1,*
  • INTRODUCTION
  • HISTOPATHOLOGICAL CLASSIFICATION OF TUMOUR
  • EPITHELIAL TUMOUR WITH SQUAMOUS DIFFERENTIATION
  • Keratinising Squamous Cell Carcinoma (KSCC)
  • Clinical Features
  • Morphology
  • Non-keratinizing Squamous Cell Carcinoma (NKSCC)
  • Clinical Features
  • Morphology
  • Prognosis and Predictive Factors
  • Squamous Cell Carcinoma
  • HPV Positive
  • Clinical Features
  • Morphology
  • Prognosis and Predictive Factor
  • Squamous Cell Carcinoma
  • HPV Negative
  • Verrucous Carcinoma
  • Morphology
  • Prognosis and Predictive Factor
  • Basaloid Squamous Cell Carcinoma
  • Morphology
  • Prognosis and Predictive Factor
  • Papillary Squamous Cell Carcinoma
  • Morphology
  • Prognosis and Predictive Factor
  • Spindle Cell Squamous Cell Carcinoma
  • Morphology
  • Prognosis and Predictive Factors
  • Adenosquamous Carcinoma (ASC)
  • Clinical Features
  • Morphology
  • Prognosis and Predictive Factors
  • NUT Carcinoma
  • Clinical Features
  • Morphology
  • Nasopharyngeal Carcinoma
  • EPITHELIAL TUMOUR WITHOUT SQUAMOUS DIFFERENTIATION
  • Sinonasal Papilloma (Schneiderian)
  • Precursor/Risk Factors
  • Morphology
  • Molecular/Genetic Profile
  • Prognosis and Predictive Factors
  • Ameloblastoma
  • Clinical Features
  • Morphology
  • Molecular/Genetic Profile
  • Prognosis/Predictive Factors
  • Sinonasal Undifferentiated Carcinoma
  • Precursor/Risk Factor
  • Morphology
  • Molecular/Genetic Profile
  • Prognosis/Predictive Factors
  • Sinonasal Adenocarcinoma, Intestinal Type
  • Precursor/Risk Factors
  • Morphology
  • Molecular/Genetic Profile
  • Prognosis/Predictive Factors
  • SALIVARY GLAND TUMOUR.
  • Microscopic Anatomy of Salivary Glands
  • Neoplasm of Salivary Glands
  • Benign and Malignant Epithelial Neoplasm
  • Pleomorphic Adenoma
  • Precursor/Risk Factors
  • Morphology
  • Molecular/Genetic Profile
  • Prognosis/Predictive Factors
  • Warthin Tumor (Papillary Cystadenoma Lymphomatosum)
  • Precursor/Risk Factors
  • Morphology
  • Prognosis/Predictive Factors
  • Mucoepidermoid Carcinoma
  • Morphology
  • Molecular/Genetic Profile
  • Prognosis and Predictive Factors
  • Adenoid Cystic Carcinoma
  • Morphology
  • Genetic and Prognosis
  • Acinic Cell Carcinoma
  • Morphology
  • Prognosis and Predictive Factors
  • MISCELLANEOUS TUMOR
  • Soft Tissue Tumors and Bone Tumors
  • Soft Tissue Tumors
  • Biphenotypic Sinonasal Sarcoma
  • Nasopharyngeal Angiofibroma
  • Spindle Cell/Pleomorphic Lipoma
  • Bone Tumors
  • Osteosarcoma
  • Chondrosarcoma
  • Chordoma
  • Hematolymphoid Tumours
  • Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL)
  • CD30-positive T-Cell Lymphoproliferative Disorder
  • Neuroendocrine Carcinoma
  • Laryngeal Neuroendocrine Carcinomas
  • Sinonasal Neuroendocrine Carcinomas
  • Paraganglion Tumours
  • Thyroid Neoplasm
  • Follicular Adenoma
  • Malignant Thyroid Neoplasm
  • CONCLUSION
  • CONSENT FOR PUBLICATION
  • CONFLICT OF INTEREST
  • ACKNOWLEDGEMENTS
  • REFERENCES
  • Inflammation, Risk Factors and Etiopathogenesis of Head and Neck Cancer
  • Norhafiza Mat Lazim*
  • INTRODUCTION
  • EPIDEMIOLOGY AND SURVIVAL RATES OF HEAD AND NECK MALIGNANCY
  • RISK FACTORS OF HEAD AND NECK MALIGNANCY AND ROLES OF INFLAMMATION
  • Smoking as A Risk Factor for Head and Neck Malignancy
  • Alcohol and Its Roles in Head and Neck Malignancy
  • Human Papilloma Virus (HPV) as a Risk Factor for Head and Neck Malignancy
  • Epstein Barr Virus (EBV) and the Inflammation
  • Dietary Factors and the Risk of Head and Neck Malignancy.
  • Genetic and Familial Inheritance in Head and Neck Malignancy
  • Chemical Carcinogen and Risk of Inflammation
  • THE INTERACTION OF RISK FACTORS IN PROMOTING INFLAMMATION AND CARCINOGENESIS
  • Smoking, Alcohol, and Oncogenic Viruses
  • Smoked Fish, Genetic and EBV
  • Obesity
  • Human Papilloma Virus HPV and Inflammations
  • PATHOGENESIS OF INFLAMMATION AND OVERALL EFFECTS ON THE HEAD AND NECK MALIGNANCY
  • CONCLUSION
  • CONSENT FOR PUBLICATION
  • CONFLICT OF INTEREST
  • ACKNOWLEDGEMENTS
  • REFERENCES
  • The Diagnostic Tools for Head and Neck Cancer
  • Giacomo Spinato1,2,*, Paolo Boscolo Rizzo1, Marco Salvatore3, Simonetta Ausoni4, Samuele Frasconi1, Giuseppe Azzarello5, Carlo Cavaliere3, Liberatore Tramontano3 and Maria Cristina Da Mosto1
  • INTRODUCTION TO DIAGNOSTIC INVESTIGATIONS IN HEAD AND NECK CANCER
  • THE ANAMNESIS ROLE IN THE DIAGNOSIS
  • CLINICAL ASSESSMENT IN HEAD AND NECK CANCER
  • CLINICAL EXAMINATION IN HEAD AND NECK CANCER
  • IMAGING TOOLS IN HEAD AND NECK
  • N staging for most tumours (except the nasopharynx and thyroid)
  • N staging of nasopharyngeal tumours (midline nodes are considered inches per secondilateral)
  • N staging for thyroid cancer
  • PREDICTIVE AND PROGNOSTIC BIOMOLECULAR TOOLS FOR HEAD AND NECK CANCER
  • Biomarkers Related to Viral Etiology
  • Biomarkers in the Era of Target Therapy and Immune Checkpoint Inhibitors
  • CONCLUSIONS
  • CONSENT FOR PUBLICATION
  • CONFLICT OF INTEREST
  • ACKNOWLEDGEMENTS
  • REFERENCES
  • The Emergence of New Inflammatory Markers of Head and Neck Cancer and their Potentials
  • Norhafiza Mat Lazim1,* and Baharudin Abdullah1
  • INTRODUCTION
  • INFLAMMATION AS A PRIMARY CAUSE OF CANCER PROGRESSION
  • EPIDEMIOLOGY OF HEAD AND NECK TUMOUR AND INFLAMMATION DRIVEN CAUSES
  • INFLAMMATION AS A POTENT RISK FACTOR FOR HEAD AND NECK MALIGNANCY
  • SIGNIFICANT INFLAMMATORY MARKERS IN HEAD AND NECK CANCER.
  • Tumor Microenvironment and Inflammatory Markers
  • Chemokines and Cytokines
  • Immune-Related Effectors
  • Role of STAT3 in HNSCC Cancer Patients
  • Role of COX2 in HNSCC Cancer Patients
  • Role of TNF in HNSCC Cancer Patients
  • Role of VEGF in HNSCC Cancer Patients
  • INFLAMMATION AS AN ANTI-CANCER THERAPEUTIC OPPORTUNITY
  • CONCLUSION
  • CONSENT FOR PUBLICATION
  • CONFLICT OF INTEREST
  • ACKNOWLEDGEMENTS
  • REFERENCES
  • Inflammation and Current HPV Status in Head and Neck Malignancy
  • Roman Carlos Zamora1,*, Jose Gutiérrez Jodas2 and Norhafiza Mat Lazim3
  • INTRODUCTION
  • CHRONIC INFLAMMATION AND HEAD AND NECK ORAL CARCINOMA
  • Oropharyngeal Carcinoma Associated with HPV
  • Human Papilloma Virus (HPV)
  • EPIDEMIOLOGY OF THE HPV RELATED HNSCC
  • CLINICAL OVERVIEW OF HPV ASSOCIATED OROPHARYNGEAL CARCINOMA
  • DIAGNOSTIC METHODS IN THE ASSESSMENT OF HPV
  • Classification HPV+ Oropharyngeal Carcinoma
  • TREATMENT OF OROPHARYNGEAL CARCINOMA ASSOCIATED WITH HPV
  • Chemotherapy De-Intensification Trials
  • PREVENTION OF HPV INFECTION
  • TREATMENT AND PREVENTION OF HPV ASSOCIATED HEAD AND NECK MALIGNANCIES
  • Current Treatment for HPV HNSCC
  • NEW POTENTIAL TREATMENT APPROACH
  • IMPLICATIONS OF NEW TREATMENT APPROACH
  • PREVENTION OF HEAD AND NECK MALIGNANCY
  • FUTURE DIRECTION AND ITS IMPACTS ON SOCIOECONOMIC
  • CONCLUSION
  • CONSENT FOR PUBLICATION
  • CONFLICT OF INTEREST
  • ACKNOWLEDGEMENTS
  • REFERENCES
  • Treatment of Head and Neck Cancer and Relation to Inflammation
  • Rohaizam Japar Jaafar1,*, Zulkifli Yusof1 and Zakinah Yahaya2
  • INTRODUCTION
  • STRATEGIES AND THERAPEUTIC TARGETS
  • Non-selective Agent to Arrest Inflammation
  • Aspirin and NSAIDs
  • Steroids
  • Statins
  • Targeted Strategies in the Tumor Microenvironment Via Cytokines, Chemokines and Specific Enzymes Manipulation.